<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01136187</url>
  </required_header>
  <id_info>
    <org_study_id>STEMI-RADIAL 16-9-2009</org_study_id>
    <nct_id>NCT01136187</nct_id>
  </id_info>
  <brief_title>Trial Comparing Radial and Femoral Approach in Primary Percutaneous Coronary Intervention (PCI)</brief_title>
  <acronym>STEMI-RADIAL</acronym>
  <official_title>ST Elevation Myocardial Infarction Treated by RADIAL or Femoral Approach - Randomized Multicenter Study Comparing Radial Versus Femoral Approach in Primary PCI. The STEMI-RADIAL Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Charles University, Czech Republic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital Pilsen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Regional Hospital Liberec</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Hospital Hradec Kralove</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Na Homolce Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Charles University, Czech Republic</source>
  <brief_summary>
    <textblock>
      Percutaneous coronary interventions (PCIs) from the femoral approach have more bleeding
      complications related to access site in comparison to the radial approach in patients with
      acute coronary syndrome (ACS). Major bleeding and access site complications have an important
      role in results of PCI for ACS and lead to higher morbidity and mortality. Primary PCIs in ST
      elevation myocardial infarction (STEMI) are associated with more aggressive antithrombotic
      treatment than in elective or semi-urgent interventions. Currently, both radial and femoral
      approaches are routinely used for primary PCI in STEMI. However, only non-randomized studies
      and registries or small randomized single center studies comparing both approaches in primary
      PCI have been published until now. The aim of STEMI-RADIAL trial is to evaluate potential
      reduction of bleeding complications in the radial approach primary PCI compared to femoral
      approach in randomized, multicenter study.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">October 2012</completion_date>
  <primary_completion_date type="Actual">April 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Occurrence of bleeding or entry site complications</measure>
    <time_frame>30 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Occurence of major adverse cardiovascular events</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Primary access site failure - conversion to another access</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Angiographical procedural success</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Contrast media consumption</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural and fluoroscopic times</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of hospital / ICU stay</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>TVR/TLR + any new hospitalization</measure>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">707</enrollment>
  <condition>ST Elevation Myocardial Infarction</condition>
  <arm_group>
    <arm_group_label>Radial approach</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Primary percutaneous coronary intervention from the radial approach</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Femoral approach</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Primary percutaneous coronary intervention from the femoral approach</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Access site in primary PCI</intervention_name>
    <arm_group_label>Radial approach</arm_group_label>
    <arm_group_label>Femoral approach</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age over 18 years

          -  Admission for STEMI less than 12 hours after onset of symptoms

               1. Patients have typical chest pain for at least 20 minutes and have ECG changes
                  typical for STEMI (ST elevation ≥ 2 mm in two continuous precordial leads or ST
                  elevations ≥ 1 mm in two limb leads or new left bundle branch block) or ECG
                  changes compatible with true posterior MI.

               2. Patients are planned to be treated with primary PCI

          -  Ability to sign written informed consent

        Exclusion Criteria:

          -  Killip IV class or unconsciousness

          -  Patient disagreement

          -  Prior aortobifemoral bypass

          -  Absence of both radial or femoral artery pulsation

          -  Participation in another clinical trial randomizing ACS patients using antithrombotic
             drug.

          -  Negative Allen's test or Barbeau test type D

          -  Treatment with oral anticoagulants
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Hospital Hradec Kralove</name>
      <address>
        <city>Hradec Kralove</city>
        <zip>50005</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Regional Hospital Liberec</name>
      <address>
        <city>Liberec</city>
        <zip>46063</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Pilsen</name>
      <address>
        <city>Pilsen</city>
        <zip>30460</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Na Homolce Hospital</name>
      <address>
        <city>Prague</city>
        <zip>15030</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Czech Republic</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 2, 2010</study_first_submitted>
  <study_first_submitted_qc>June 2, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 3, 2010</study_first_posted>
  <last_update_submitted>December 20, 2012</last_update_submitted>
  <last_update_submitted_qc>December 20, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 21, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Charles University, Czech Republic</investigator_affiliation>
    <investigator_full_name>Ivo Bernat</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Myocardial infarction</keyword>
  <keyword>Primary percutaneous coronary intervention</keyword>
  <keyword>Radial</keyword>
  <keyword>Bleeding</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>ST Elevation Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

